About US
Contact us
-
Pfizer's Ibrance clears first hurdle to early access in U.K.Pfizer's ($PFE) new cancer standout,Ibrance, has taken its first step toward joining the U.K.'s Early Access to Medicines program, winning the "promising innovative medicine" tag from the country's Me2016/1/25
-
FDA bans products from China plant used by Big Pharma playersA Chinese drug-ingredient maker who has produced active ingredients for some of the big guns in pharma now faces an FDA ban in the U.S. The agency added Zhejiang Hisoar Pharmaceutical to its import al2016/1/25
-
Acquisition of Pharmaceutical Sugar Spheres Product Line from Paulaur Corporation19th January 2016 Subject: Acquisition of Pharmaceutical Sugar Spheres Product Line from Paulaur Corporation Dear Customer: We are pleased to announce that effective 18th January 2016, Colorcon,2016/1/22
-
US FDA grants priority review to Eisai’s new drug application for anticancer drug lenvatinibThe US Food and Drug Administration (FDA) has granted priority review status to the supplemental new drug application (sNDA) submitted by Eisai for its anticancer agent lenvatinib mesylate, as a treat2016/1/20
-
US FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis treatmentSwiss drug maker Novartis has secured approvals from the US Food and Drug Administration (FDA) for injectable medication Cosentyx for two new indications, which can now be used to treat patients havin2016/1/20
-
Wockhardt spanked again by FDA as agency ticks off violations at new sterile injectables plantWockhardt saw a new plant that will make sterile injectable drugs as its best shot at restoring a U.S. business devastated byFDAproduct bans.But the Indian company said today that facility--a plant it2016/1/19
-
It's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdownMerck KGaA wins U.K. ruling, but Merck & Co. says it will file its own lawsuit in U.S. Merck has won a legal battle over Merck, which in return says it will file a lawsuit against Merck. It sound2016/1/19
-
Merck agrees to acquire UK's IOmet PharmaMerck has entered into an agreement to acquire IOmet Pharma, a UK-based small-molecule drug developer focused on cancer immunotherapy and cancer metabolism, for an undisclosed price. Following comple2016/1/18
-
Sanofi and Warp Drive to develop new oncology therapies and antibioticsFrench pharmaceutical firm Sanofi has entered into a new collaboration with Warp Drive Bio, a US-based biotechnology firm using the molecules and mechanisms of nature to discover and develop transform2016/1/18
-
Boehringer and Arena to develop new drugs for psychiatric diseasesGerman pharmaceutical firm Boehringer Ingelheim has signed an exclusive agreement with US-based Arena Pharmaceuticals, to conduct joint research to discover new drug candidates for psychiatric disease2016/1/15